Neoplasms, Germ Cell and Embryonal
"Neoplasms, Germ Cell and Embryonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.
| Descriptor ID |
D009373
|
| MeSH Number(s) |
C04.557.465
|
| Concept/Terms |
Neoplasms, Germ Cell- Neoplasms, Germ Cell
- Germ Cell Tumor
- Germ Cell Tumors
- Tumor, Germ Cell
- Tumors, Germ Cell
- Germ Cell Neoplasms
Cancer, Embryonal- Cancer, Embryonal
- Cancers, Embryonal
- Embryonal Cancer
- Embryonal Cancers
Germ Cell Cancer- Germ Cell Cancer
- Cancer, Germ Cell
- Cancers, Germ Cell
- Germ Cell Cancers
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Germ Cell and Embryonal".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Germ Cell and Embryonal".
This graph shows the total number of publications written about "Neoplasms, Germ Cell and Embryonal" by people in this website by year, and whether "Neoplasms, Germ Cell and Embryonal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 5 | 0 | 5 |
| 2018 | 4 | 1 | 5 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 1 | 4 |
| 2022 | 4 | 1 | 5 |
| 2023 | 4 | 0 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Germ Cell and Embryonal" by people in Profiles.
-
Overcoming the Code Duello: Achieving Long-term Cure and Optimizing Quality of Life in Testicular Cancer. Eur Urol Focus. 2024 May; 10(3):355-356.
-
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer. J Clin Oncol. 2023 Dec 01; 41(34):5296-5305.
-
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma. Int J Gynecol Pathol. 2024 Jan 01; 43(1):90-96.
-
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J Clin Oncol. 2023 06 01; 41(16):3009-3018.
-
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. Eur J Cancer. 2023 03; 182:144-154.
-
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study. Urol Oncol. 2023 02; 41(2):111.e7-111.e14.
-
Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium. Br J Cancer. 2022 11; 127(9):1577-1583.
-
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting. J Mol Diagn. 2022 08; 24(8):867-877.
-
ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol. 2022 05; 19(5S):S194-S207.
-
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility. World J Urol. 2022 Jun; 40(6):1505-1512.